COVID-19 vaccination-associated myelitis
Hardeep Singh MalhotraDepartment of Neurology, King George’s Medical University, Lucknow 226003, Uttar Pradesh, IndiaPriyanka GuptaDepartment of Neurology, King George’s Medical University, Lucknow 226003, Uttar Pradesh, IndiaVikas PrabhuDepartment of Neurology, King George’s Medical University, Lucknow 226003, Uttar Pradesh, IndiaRavindra Kumar GargDepartment of Neurology, King George’s Medical University, Lucknow 226003, Uttar Pradesh, IndiaHimanshu DanduDepartment of Infectious Diseases, King George’s Medical University, Lucknow 226003, Uttar Pradesh, IndiaVikasendu Agarwal
2021en
ABI
Аннотация
Of all COVID-19 vaccination-associated adverse events, 2.69% may be neurological in nature. We report the first case of myelitis from India with ChAdOX1 nCoV-19 vaccine; the patient had excellent recovery. Having occurred after an administration of > 50 million doses, benefits of vaccination seem to outweigh the risk of adverse events.
Ҳали таржима қилинмаган
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба